Our Authors
Mr Lance Kawaguchi is an internationally recognised executive leader and board member, with over 25 years of global finance and banking experience, including living and working throughout North America, Europe, Asia Pacific, and the Middle East. He has a strong advocational vision for supporting people and families living with brain cancer, while advancing the foundation’s visibility and objectives with like-minded members of the global corporate and scientific community. Lance has experienced first-hand the impacts of cancer, losing his mother to the disease in 2016. In her memory, he has committed to utilising his skills and talents to positively impact and drive change in the sector. Throughout his career, Lance’s outstanding leadership and innovative approach to diversity and inclusion have seen him recognised by many peak global bodies including the Treasury Management International, prestigious BAME100 Board Talent Index and as one of UPstanding’s 100 leading ethnic minority executives.1 Articles
Prof John Boyages AM is a breast cancer specialist with over 38 years of experience in the diagnosis and treatment of breast cancer. He trained at the University of Sydney and the Dana Farber Cancer Institute at Harvard University. He is a radiation oncologist at Icon Cancer Centre Wahroonga, located within the Sydney Adventist Hospital, and at Icon Cancer Centre Gosford. He has published more than 190 research papers, alongside establishing breast cancer screening, treatment and lymphoedema programs. He is the author of four Taking Control series of books for patients (www.bcpublish.com). Prof Boyages is a Professor of Medicine at the ANU Medical School, ANU College of Health and Medicine. He is also an honorary Professor and founding Director of the ALERT lymphoedema program. In 2017, he was awarded an Order of Australia for his work with breast cancer and radiation oncology. John consults and treats patients at Icon Cancer Centre Gosford as part of the Central Coast multidisciplinary team. Learn more: https://iconcancercentre.com.au/doctor/john-boyages-am/1 Articles
Liz Lobb is Professor of Palliative Care (Allied Health) at Calvary Health Care Kogarah and Deputy Chair of the Calvary Palliative and End of Life Care Research Institute. She is an Adjunct Professor in the School of Medicine at the University of Notre Dame, Sydney and the Faculty of Health at the University of Technology, Sydney. Professor Lobb obtained her PhD in Psychological Medicine from the Faculty of Medicine at the University of Sydney. She has worked clinically as a bereavement counsellor and educator and in psycho-oncology and palliative care research for 25 years.1 Articles
Eisai Co., Ld. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. For more information visit our Company Page on Oncology News or our Website.
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis and help patients with infertility, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. For more information visit our Company Page on Oncology News or our Website.
Dr Bourne was also one of the first Urologists in Queensland to establish Brachytherapy treatment for prostate cancer at Greenslopes Private Hospital and the first and currently the only one to offer this treatment at the John Flynn Private Hospital Gold Coast. Dr Bourne Established his private practice in 2000 providing a comprehensive range of urological services at the John Flynn Private Hospital and the Tweed Heads and Murwillumbah District Hospital. Dr Bourne also provides education and training to the urological registrar’s at the Tweed Heads and Murwillumbah District Hospital.
Associate Professor Caroline Ford is a cancer researcher within the School of Women's and Children's Health at the Lowy Cancer Research Centre. After completing her PhD at UNSW on the topic of oncogenic viruses, A/Prof Ford undertook two international postdoctoral appointments in cancer research. Her first postdoctoral research appointment was at the University of Toronto, Canada and the second appointment was at Lund University, Sweden. She returned to UNSW in late 2009 funded by an NHMRC CJ Martin Fellowship and established her research group within the Adult Cancer Program. A/Prof Ford leads the Gynaecological Cancer Research Group (GCRG), which aims to understand why gynaecological cancers develop, how and why they spread throughout the body, and how best to treat them. “Gynaecological cancer” encompasses all cancers of the female reproductive system, though our current research focuses on ovarian and endometrial cancer. The GCRG works closely with clinical staff at the Royal Hospital for Women, and has a number of studies involving sample collection from patients. Current projects include the development of an early detection test for ovarian cancer, and the identification of key targets for anti-metastatic therapies in ovarian and endometrial cancer. We are also investigating properties of ascites, a fluid build-up associated with aggressive disease. A/Prof Ford is an experienced university lecturer, convening courses on medical research, cancer pathology and personalised medicine, including Australia's first MOOC (Massive Open Online Course) on Personalised Medicine. She has completed a Graduate Certificate in University Learning & Teaching, and is passionate about science communication and enhancing the health literacy of the wider community. In 2017 she was named as an inaugural ‘Superstar of STEM’ by Science & Technology Australia. In 2018 she received the Women's Agenda Award for Female Leader in Science, Medicine & Health.
